Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

IMW 2021 | Key highlights of IMW 2021

Heinz Ludwig, MD, of the Wilhelminen Cancer Research Institute, Wilhelminenspital, Vienna, Austria, and Hermann Einsele, MD, FRCP, of the University of Würzburg, Würzburg, Germany, outline the key sessions and topics discussed during the 18th International Myeloma Workshop (IMW) meeting. Prof. Ludwig talks on sessions covering the latest insights into the molecular mechanisms of myeloma, updated clinical trial data on the treatment of newly-diagnosed patients, as well as the importance of transplant. This interview took place during the IMW 2021 congress.

Disclosures

Heinz Ludwig, MD, has received research funding from Amgen and Takeda; and has received speaker’s honoraria and has participated in advisory boards for Amgen, Takeda, Sanofi, Janssen, Celgene-BMS and Seattle Genetics.